晚期/转移性实体瘤的临床试验
总计7697个结果
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的
-
National Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 不可切除的恶性实体肿瘤 | 转移性恶性实体瘤美国
-
National Cancer Institute (NCI)完全的
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.招聘中
-
Suzhou Genhouse Bio Co., Ltd.Zhejiang Cancer Hospital; Henan Cancer Hospital; Hubei Cancer Hospital; The First Affiliated Hospital...招聘中
-
Shanghai YingLi Pharmaceutical Co. Ltd.尚未招聘
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Zhejiang Cancer Hospital; Fudan University招聘中
-
TCRCure Biopharma Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences招聘中
-
Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.Sponsor GmbH招聘中
-
Gannex Pharma Co., Ltd.Ascletis Pharmaceuticals Co., Ltd.招聘中
-
Wuxi People's HospitalImbioray (Hangzhou) Biomedicine Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC招聘中
-
Regeneron Pharmaceuticals招聘中
-
Jiangsu HengRui Medicine Co., Ltd.Atridia Pty Ltd.招聘中